The gut feeling

This video explains how people are venturing in to microbiome. Advances in DNA sequencing and big data allow us to analyse bacteria like never before. Scientists and entrepreneurs have entered a race to develop tools and datasets that uncover the role microbes play in human health.

Bacteria are no longer the enemy. Will bacteria enable personalized medicine?
Yes, there are many companies that focus on the microbiome that could transform multi-billion dollar concerns like weight loss, probiotics, cosmetics, dental health, and even chronic diseases like diabetes. Will microbiome analysis change modern medicine? How are entrepreneurs involved? Is the money in sequencing, analytics, or drug development?

BugSpeaks®

BugSpeaks®, developed by Leucine Rich Bio Pvt Ltd, South Asia’s first microbiome company, is headquartered in Bengaluru, India. Since 2014, the company has pioneered advanced analytics to analyze complex genomics data. Collaborating with leading research institutes globally, Leucine Rich Bio has leveraged its expertise to create BugSpeaks®, South Asia’s first gut microbiome test.